Replies to post #203580 on Biotech Values

[jbog]

Auris Medical Reports Top-Line Results from TACTT2 Trial with Keyzilen in Acute Inner Ear Tinnitus

GlobeNewswire•August 18,2016

TACTT2 trial did not meet its co-primary efficacy endpoints

Top-line results from the Phase 3 TACTT3 trial expected in the fourth quarter of 2016

Second quarter 2016 financial results and conference call scheduled for today

http://finance.yahoo.com/news/auris-medical-reports-top-line-102517051.html